Insider sale
DYNE THERAPEUTICS, INC.
$762.1K
43.62K shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 43.62K shares of DYNE THERAPEUTICS, INC. valued at approximately $762.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/6/2026ACC: 0001628280-26-031384
10% Owner
Since Sep 2020
43.62K
Shares to sell
$762.1K
Approx. market value
43.62K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/31/2020
43.62KTotal acquired43.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2020 | Private Placement Cash | 43.62K | — |
| Total | 43.62K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
43.62K
Market value
$762.1K
5/6/2026
Total
Units
43.62K
Value
$762.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/6/2026 | 43.62K | $762.1K | Nasdaq | Planned |
| Total | 43.62K | $762.1K | ||